Louise Bannon: Thomas Reiser to Step Down as ISTH Executive Director
Louise Bannon, Director of Membership, Marketing and External Relations of ISTH, reposted from International Society on Thrombosis and Haemostasis on LinkedIn:
”Today, the International Society on Thrombosis and Haemostasis (ISTH) shared that Thomas Reiser will step down as Executive Director at the end of 2025.
Tom has led the Society with dedication and strategic vision for more than 14 years, and we are deeply grateful for his tremendous service, mentorship and commitment to strengthening our global community. We look forward to continuing to work closely with him through the remainder of the year as we prepare for this transition.
I am honored to step into the role of Interim Executive Director on January 1 and it is a privilege to serve our members, partners and the global thrombosis and hemostasis community during this important chapter for the Society.
Our mission remains clear and our momentum strong. In the months ahead, I look forward to partnering with our exceptional staff, volunteer leaders and valued stakeholders to continue advancing science, education and advocacy for the benefit of patients worldwide.
To all who support our work, especially our talented staff, thank you. Your dedication and heart power everything we do. I feel fortunate to work alongside you and look forward to continuing our important work together in the months ahead.”
Quoting International Society on Thrombosis and Haemostasis‘s post:
”The ISTH announces that Thomas Reiser will step down from his position as Executive Director, following a commendable 14-year period of leadership at the Society. As part of a carefully planned transition, the ISTH Council appoints Louise St. Germain, ISTH Director of Membership, Marketing and External Relations, to the role of Interim Executive Director effective on January 1, 2026. As the search for a permanent Executive Director commences, the ISTH looks forward to the opportunities ahead and to the Society continuing to evolve, innovate and strengthen its impact for the benefit of the global thrombosis and hemostasis community.
Read more.”
Stay updated with Hemostasis Today.
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
-
Dec 16, 2025, 11:30Kingsley Wheaton: Sweden is on the Brink of Becoming the World’s 1st Smoke-Free Country